These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 1771698)

  • 1. Metabolism of pyridoxine in mild metabolic hyperoxaluria and primary hyperoxaluria (type 1).
    Edwards P; Rose GA
    Urol Int; 1991; 47(3):113-7. PubMed ID: 1771698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vitamin B6 metabolites in idiopathic calcium stone formers: no evidence for a link to hyperoxaluria.
    Kaelin A; Casez JP; Jaeger P
    Urol Res; 2004 Feb; 32(1):61-8. PubMed ID: 14628106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pyridoxine can normalize oxaluria in idiopathic renal lithiasis].
    Jaeger P; Portmann L; Jacquet AF; Burckhardt P
    Schweiz Med Wochenschr; 1986 Dec; 116(50):1783-6. PubMed ID: 3798070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sensitivity to meat protein intake and hyperoxaluria in idiopathic calcium stone formers.
    Nguyen QV; Kälin A; Drouve U; Casez JP; Jaeger P
    Kidney Int; 2001 Jun; 59(6):2273-81. PubMed ID: 11380831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple mechanisms of action of pyridoxine in primary hyperoxaluria type 1.
    Fargue S; Rumsby G; Danpure CJ
    Biochim Biophys Acta; 2013 Oct; 1832(10):1776-83. PubMed ID: 23597595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A simple liquid-chromatographic method for measuring vitamin B6 compounds in plasma.
    Edwards P; Liu PK; Rose GA
    Clin Chem; 1989 Feb; 35(2):241-5. PubMed ID: 2914368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of oral pyridoxine upon plasma and 24-hour urinary oxalate levels in normal subjects and stone formers with idiopathic hypercalciuria.
    Edwards P; Nemat S; Rose GA
    Urol Res; 1990; 18(6):393-6. PubMed ID: 2100414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mild metabolic hyperoxaluria and its response to pyridoxine.
    Gill HS; Rose GA
    Urol Int; 1986; 41(5):393-6. PubMed ID: 3811039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperoxaluria type I: therapeutic effects of pyridoxine hydrochloride and inheritance patterns of the disease in a family.
    Yano S; Yoshino M; Nishiyori A; Nakao M; Matsumoto T; Ito Y; Yamashita F; Shimada A; Inokuchi T
    Kurume Med J; 1988; 35(3):127-33. PubMed ID: 3236825
    [No Abstract]   [Full Text] [Related]  

  • 10. Plasma B-6 vitamer and plasma and urinary 4-pyridoxic acid concentrations in young women as determined using high performance liquid chromatography.
    Driskell JA; Chrisley BM
    Biomed Chromatogr; 1991 Sep; 5(5):198-201. PubMed ID: 1742549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endogenous Oxalate Production in Primary Hyperoxaluria Type 1 Patients.
    Garrelfs SF; van Harskamp D; Peters-Sengers H; van den Akker CHP; Wanders RJA; Wijburg FA; van Goudoever JB; Groothoff JW; Schierbeek H; Oosterveld MJS
    J Am Soc Nephrol; 2021 Dec; 32(12):3175-3186. PubMed ID: 34686543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary hyperoxaluria: effect of treatment with vitamin B6 and shock waves.
    Amato M; Donzelli S; Lombardi M; Salvadori M; Carini M; Selli C; Caudarella R
    Contrib Nephrol; 1987; 58():190-2. PubMed ID: 3691125
    [No Abstract]   [Full Text] [Related]  

  • 13. Plasma oxalate and creatinine and oxalate/creatinine clearance ratios in normal subjects and in primary hyperoxaluria. Evidence for renal hyperoxaluria.
    Kasidas GP; Nemat S; Rose GA
    Clin Chim Acta; 1990 Oct; 191(1-2):67-77. PubMed ID: 2073734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma content of B6 vitamers and its relationship to hepatic vitamin B6 metabolism.
    Lumeng L; Lui A; Li TK
    J Clin Invest; 1980 Oct; 66(4):688-95. PubMed ID: 7419716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Response to a physiologic dose of pyridoxine in type I primary hyperoxaluria.
    Yendt ER; Cohanim M
    N Engl J Med; 1985 Apr; 312(15):953-7. PubMed ID: 3974685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pyridoxine effect in type I primary hyperoxaluria is associated with the most common mutant allele.
    Monico CG; Rossetti S; Olson JB; Milliner DS
    Kidney Int; 2005 May; 67(5):1704-9. PubMed ID: 15840016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Results of long-term treatment with orthophosphate and pyridoxine in patients with primary hyperoxaluria.
    Milliner DS; Eickholt JT; Bergstralh EJ; Wilson DM; Smith LH
    N Engl J Med; 1994 Dec; 331(23):1553-8. PubMed ID: 7969325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pyridoxic acid excretion during low vitamin B-6 intake, total fasting, and bed rest.
    Coburn SP; Thampy KG; Lane HW; Conn PS; Ziegler PJ; Costill DL; Mahuren JD; Fink WJ; Pearson DR; Schaltenbrand WE
    Am J Clin Nutr; 1995 Nov; 62(5):979-83. PubMed ID: 7572745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vitamin B6 nutritional status in asthma: the effect of theophylline therapy on plasma pyridoxal-5'-phosphate and pyridoxal levels.
    Delport R; Ubbink JB; Serfontein WJ; Becker PJ; Walters L
    Int J Vitam Nutr Res; 1988; 58(1):67-72. PubMed ID: 3384587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Timing of renal transplantation in the management of pyridoxine-resistant type I primary hyperoxaluria.
    Watts RW; Morgan SH; Purkiss P; Mansell MA; Baker LR; Brown CB
    Transplantation; 1988 Jun; 45(6):1143-5. PubMed ID: 3289157
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.